Valeant Pharmaceuticals International, Inc. (VRX) recently announced that the company has entered into a definitive agreement to acquire all of the outstanding common stock of Obagi Medical Products, Inc. (OMPI) for $19.75 per share …
It comprises two operational divisions dedicated to serve the pharmaceutical industry: Pharmaceutical Systems with …
Kubayi would also have had to answer several questions from DA MP Gordon Mackay on the recent suspension of her department's director-general for policy, planning and clean energy, Ompi Aphane ... up of the strategic fuel stock sale …
Collectively, the two own 0.7 percent of outstanding common stock, according to Thomson Reuters data ... its intention to replace the entire board of Obagi Medical Products Inc OMPI.O. Soon after that Obagi said it would be sold to Valeant …
Since then, the target of one-million SWHs has been reiterated and, at the most recent workshop, DoE acting deputy director-general for electricity Ompi Aphane explained that ... which excludes old housing stock and low-income housing.
Obagi Medical Products (Nasdaq: OMPI) today announced the results for a recent trial evaluating its solubilized benzoyl peroxide for the treatment of acne. Named CLENZIderm M.D.(TM), the product showed it may provide dramatic …
Valeant Pharmaceuticals’ (VRX) proposed acquisition of Obagi Medical Products, Inc. (OMPI) received a boost with Merz Pharma ... In Dec 2012, Valeant acquired the entire outstanding common stock of Medicis Pharmaceutical Corporation …
Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic ... 1.5 million shares of …
Vancouver, BC, May 15, 2012 - (ACN Newswire) - Shares of Obagi Medical Products (NASDAQ:OMPI - News) rose 4.69% on Monday to $ ... andestimated a U.S. license for ~$250M with +$2-3 upside to the stock," wrote Rivkind. " We think …
Collectively, the two own 0.7 percent of outstanding common stock, according to Thomson Reuters data ... its intention to replace the entire board of Obagi Medical Products Inc (OMPI.O). Soon after that Obagi said it would be sold to Valeant ...